NCT00195234View on ClinicalTrials.gov

Study Evaluating Vaccine in Adults With HIV

PHASE1CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

December 31, 2004

Study Completion Date

February 28, 2007

Conditions
HIV Infections
Interventions
BIOLOGICAL

HIV CTL MEP 1000 micrograms, 19 months per subject

Trial Locations (10)

10003

New York

19104

Philadelphia

60612

Chicago

75246

Dallas

78705

Austin

80262

Denver

95817

Sacramento

44106-5083

Cleveland

37232-2582

Nashville

75390-9103

Dallas

All Listed Sponsors
lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00195234 - Study Evaluating Vaccine in Adults With HIV | Biotech Hunter | Biotech Hunter